Scientists track COVID-19 immunity in vulnerable CF patients
NCT ID NCT04992234
Summary
This study aimed to understand how people with cystic fibrosis (CF) respond to COVID-19. Researchers followed 113 children and adults with CF in Europe for two years, checking their blood for COVID-19 antibodies at regular clinic visits. The goal was to see how many got infected, how their bodies reacted after infection or vaccination, and if having COVID-19 changed the course of their CF.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Karolinska University Hospital
Huddinge, Sweden
-
Sahlgrenska University Hospital
Gothenburg, Sweden
Conditions
Explore the condition pages connected to this study.